A regulatory look at nicotine analogues in the US market

Vaping and oral snuff products containing synthetic nicotine analogues have been found in the US marketplace this year. These products are promoted as exempt from the US Food and Drug Administration (FDA) premarket tobacco product application (PMTA) process and avoid federal and state regulations.

This report explains what nicotine analogues are and what their current US federal legal status is, looks at criticism for the FDA’s lack of regulations on them, and predicts the future of these compounds in the country.


Free sample
I'm already a subscriber

Kristina Iashina

Junior legal analyst
Kristina holds a Masters Degree in International Law from Moscow State Linguistic University, Russia. In 2020 she completed a six-month exchange programme at the University of Malaga. She has worked as a legal secretary at the Ninth Arbitration Court of Appeal, Russia; and as a legal assistant in a law firm in Moscow.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization